CHINA PHARMA HOLDINGS, INC. Construction Loan
CHINA PHARMA HOLDINGS, INC. (CPHI) had Construction Loan of $440.00 thousand as of 2022-12-31, per its 10-K filed 2023-03-30.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Debt, Current › Short-Term Debt
us-gaap:ConstructionLoan · last filed 2023-08-14
- 2022-12-30: Construction Loan 3.80M CNY.
- 2022-12-21: Construction Loan 7.30M CNY.
- 2021-09-30: Construction Loan 3.20M CNY.
- 2021-09-18: Construction Loan 10.00M CNY.
CNY
| Period end | Construction Loan |
|---|---|
| 2022-12-30 | 3.80M CNY 10-Q · filed 2023-08-14 |
| 2022-12-21 | 7.30M CNY 10-Q · filed 2023-08-14 |
| 2021-09-30 | 3.20M CNY 10-K · filed 2023-03-30 |
| 2021-09-18 | 10.00M CNY 10-Q · filed 2023-08-14 |
| 2020-09-30 | 3.20M CNY 10-K · filed 2023-03-30 |
| 2020-06-30 | 8.50M CNY 10-Q · filed 2022-08-11 |
| 2013-06-21 | 80.00M CNY 10-K · filed 2023-03-30 |
USD
| Period end | Construction Loan | Construction Loan as first filed |
|---|---|---|
| 2022-12-31 | $440.00K 10-K · filed 2023-03-30 | |
| 2022-12-30 | $560.00K 10-Q · filed 2023-08-14 | |
| 2022-12-21 | $1.00M 10-Q · filed 2023-08-14 | |
| 2021-09-30 | $800.00K 10-K · filed 2023-03-30 | |
| 2021-09-18 | $1.54M 10-Q · filed 2023-08-14 | |
| 2020-06-30 | $1.20M 10-Q · filed 2022-08-11 | $8.50M 10-Q · filed 2020-08-13 |
| 2020-04-30 | $1.40M 10-Q · filed 2021-08-13 | |
| 2019-06-30 | $2.00M 10-Q · filed 2019-08-14 | |
| 2013-06-21 | $13.00M 10-K · filed 2023-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |